nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCB1—esophageal cancer	0.362	1	CbGaD
Apixaban—ABCG2—Carboplatin—esophageal cancer	0.111	0.259	CbGbCtD
Apixaban—ABCG2—Cisplatin—esophageal cancer	0.0946	0.221	CbGbCtD
Apixaban—CYP2C9—Capecitabine—esophageal cancer	0.0698	0.163	CbGbCtD
Apixaban—ABCG2—Methotrexate—esophageal cancer	0.0614	0.144	CbGbCtD
Apixaban—CYP2C9—Cisplatin—esophageal cancer	0.0352	0.0821	CbGbCtD
Apixaban—ABCB1—Cisplatin—esophageal cancer	0.0341	0.0797	CbGbCtD
Apixaban—ABCB1—Methotrexate—esophageal cancer	0.0222	0.0517	CbGbCtD
Apixaban—Wound secretion—Capecitabine—esophageal cancer	0.00381	0.105	CcSEcCtD
Apixaban—Drug hypersensitivity—Capecitabine—esophageal cancer	0.00137	0.0379	CcSEcCtD
Apixaban—Haematochezia—Capecitabine—esophageal cancer	0.00137	0.0379	CcSEcCtD
Apixaban—Haematoma—Capecitabine—esophageal cancer	0.000879	0.0243	CcSEcCtD
Apixaban—Haematemesis—Capecitabine—esophageal cancer	0.000795	0.022	CcSEcCtD
Apixaban—Metrorrhagia—Capecitabine—esophageal cancer	0.000773	0.0214	CcSEcCtD
Apixaban—Vaginal haemorrhage—Capecitabine—esophageal cancer	0.000746	0.0206	CcSEcCtD
Apixaban—Haemoptysis—Capecitabine—esophageal cancer	0.000746	0.0206	CcSEcCtD
Apixaban—Petechiae—Capecitabine—esophageal cancer	0.000671	0.0186	CcSEcCtD
Apixaban—Contusion—Capecitabine—esophageal cancer	0.000633	0.0175	CcSEcCtD
Apixaban—Rectal haemorrhage—Capecitabine—esophageal cancer	0.000612	0.0169	CcSEcCtD
Apixaban—Haematemesis—Methotrexate—esophageal cancer	0.000592	0.0164	CcSEcCtD
Apixaban—Blood bilirubin increased—Capecitabine—esophageal cancer	0.000584	0.0161	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000544	0.015	CcSEcCtD
Apixaban—Melaena—Capecitabine—esophageal cancer	0.00054	0.0149	CcSEcCtD
Apixaban—Petechiae—Methotrexate—esophageal cancer	0.0005	0.0138	CcSEcCtD
Apixaban—Ecchymosis—Capecitabine—esophageal cancer	0.000499	0.0138	CcSEcCtD
Apixaban—Breast disorder—Cisplatin—esophageal cancer	0.000492	0.0136	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00049	0.0135	CcSEcCtD
Apixaban—Diabetes mellitus—Capecitabine—esophageal cancer	0.000461	0.0127	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.000461	0.0127	CcSEcCtD
Apixaban—Melaena—Methotrexate—esophageal cancer	0.000402	0.0111	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000401	0.0111	CcSEcCtD
Apixaban—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000396	0.011	CcSEcCtD
Apixaban—Ecchymosis—Methotrexate—esophageal cancer	0.000372	0.0103	CcSEcCtD
Apixaban—Urinary tract disorder—Cisplatin—esophageal cancer	0.000372	0.0103	CcSEcCtD
Apixaban—Liver function test abnormal—Capecitabine—esophageal cancer	0.00037	0.0102	CcSEcCtD
Apixaban—Connective tissue disorder—Cisplatin—esophageal cancer	0.00037	0.0102	CcSEcCtD
Apixaban—Urethral disorder—Cisplatin—esophageal cancer	0.000369	0.0102	CcSEcCtD
Apixaban—Breast disorder—Capecitabine—esophageal cancer	0.000362	0.01	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000361	0.00998	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000354	0.00978	CcSEcCtD
Apixaban—Eye disorder—Cisplatin—esophageal cancer	0.000352	0.00972	CcSEcCtD
Apixaban—Diabetes mellitus—Methotrexate—esophageal cancer	0.000343	0.00949	CcSEcCtD
Apixaban—Immune system disorder—Cisplatin—esophageal cancer	0.00034	0.0094	CcSEcCtD
Apixaban—Mediastinal disorder—Cisplatin—esophageal cancer	0.000339	0.00938	CcSEcCtD
Apixaban—Anaemia—Cisplatin—esophageal cancer	0.000303	0.00837	CcSEcCtD
Apixaban—Haematuria—Capecitabine—esophageal cancer	0.000295	0.00815	CcSEcCtD
Apixaban—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000292	0.00808	CcSEcCtD
Apixaban—Epistaxis—Capecitabine—esophageal cancer	0.000291	0.00806	CcSEcCtD
Apixaban—Haemoglobin—Capecitabine—esophageal cancer	0.000279	0.00771	CcSEcCtD
Apixaban—Haemorrhage—Capecitabine—esophageal cancer	0.000277	0.00767	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000277	0.00766	CcSEcCtD
Apixaban—Liver function test abnormal—Methotrexate—esophageal cancer	0.000276	0.00762	CcSEcCtD
Apixaban—Urinary tract disorder—Capecitabine—esophageal cancer	0.000274	0.00757	CcSEcCtD
Apixaban—Connective tissue disorder—Capecitabine—esophageal cancer	0.000273	0.00754	CcSEcCtD
Apixaban—Urethral disorder—Capecitabine—esophageal cancer	0.000272	0.00752	CcSEcCtD
Apixaban—Breast disorder—Methotrexate—esophageal cancer	0.00027	0.00746	CcSEcCtD
Apixaban—Anaphylactic shock—Cisplatin—esophageal cancer	0.000267	0.00739	CcSEcCtD
Apixaban—Nervous system disorder—Cisplatin—esophageal cancer	0.000262	0.00725	CcSEcCtD
Apixaban—Thrombocytopenia—Cisplatin—esophageal cancer	0.000262	0.00724	CcSEcCtD
Apixaban—Skin disorder—Cisplatin—esophageal cancer	0.00026	0.00718	CcSEcCtD
Apixaban—Eye disorder—Capecitabine—esophageal cancer	0.000259	0.00717	CcSEcCtD
Apixaban—Angiopathy—Capecitabine—esophageal cancer	0.000252	0.00696	CcSEcCtD
Apixaban—Immune system disorder—Capecitabine—esophageal cancer	0.000251	0.00693	CcSEcCtD
Apixaban—Mediastinal disorder—Capecitabine—esophageal cancer	0.00025	0.00691	CcSEcCtD
Apixaban—Hypotension—Cisplatin—esophageal cancer	0.00025	0.00691	CcSEcCtD
Apixaban—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000231	0.00638	CcSEcCtD
Apixaban—Anaemia—Capecitabine—esophageal cancer	0.000223	0.00617	CcSEcCtD
Apixaban—Haematuria—Methotrexate—esophageal cancer	0.000219	0.00606	CcSEcCtD
Apixaban—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000218	0.00601	CcSEcCtD
Apixaban—Epistaxis—Methotrexate—esophageal cancer	0.000217	0.006	CcSEcCtD
Apixaban—Syncope—Capecitabine—esophageal cancer	0.000217	0.00599	CcSEcCtD
Apixaban—Loss of consciousness—Capecitabine—esophageal cancer	0.000212	0.00587	CcSEcCtD
Apixaban—Haemoglobin—Methotrexate—esophageal cancer	0.000208	0.00574	CcSEcCtD
Apixaban—Haemorrhage—Methotrexate—esophageal cancer	0.000206	0.00571	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000204	0.00564	CcSEcCtD
Apixaban—Urinary tract disorder—Methotrexate—esophageal cancer	0.000204	0.00564	CcSEcCtD
Apixaban—Urethral disorder—Methotrexate—esophageal cancer	0.000202	0.0056	CcSEcCtD
Apixaban—Hypersensitivity—Cisplatin—esophageal cancer	0.000197	0.00545	CcSEcCtD
Apixaban—Shock—Capecitabine—esophageal cancer	0.000194	0.00536	CcSEcCtD
Apixaban—Nervous system disorder—Capecitabine—esophageal cancer	0.000193	0.00534	CcSEcCtD
Apixaban—Eye disorder—Methotrexate—esophageal cancer	0.000193	0.00534	CcSEcCtD
Apixaban—Thrombocytopenia—Capecitabine—esophageal cancer	0.000193	0.00533	CcSEcCtD
Apixaban—Skin disorder—Capecitabine—esophageal cancer	0.000191	0.00529	CcSEcCtD
Apixaban—Angiopathy—Methotrexate—esophageal cancer	0.000187	0.00518	CcSEcCtD
Apixaban—Immune system disorder—Methotrexate—esophageal cancer	0.000187	0.00516	CcSEcCtD
Apixaban—Mediastinal disorder—Methotrexate—esophageal cancer	0.000186	0.00515	CcSEcCtD
Apixaban—Hypotension—Capecitabine—esophageal cancer	0.000184	0.00509	CcSEcCtD
Apixaban—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00017	0.0047	CcSEcCtD
Apixaban—Rash—Cisplatin—esophageal cancer	0.000169	0.00466	CcSEcCtD
Apixaban—Dermatitis—Cisplatin—esophageal cancer	0.000168	0.00466	CcSEcCtD
Apixaban—Anaemia—Methotrexate—esophageal cancer	0.000166	0.00459	CcSEcCtD
Apixaban—Nausea—Cisplatin—esophageal cancer	0.000159	0.00439	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000152	0.0042	CcSEcCtD
Apixaban—Anaphylactic shock—Methotrexate—esophageal cancer	0.000147	0.00406	CcSEcCtD
Apixaban—Hypersensitivity—Capecitabine—esophageal cancer	0.000145	0.00401	CcSEcCtD
Apixaban—Nervous system disorder—Methotrexate—esophageal cancer	0.000144	0.00398	CcSEcCtD
Apixaban—Thrombocytopenia—Methotrexate—esophageal cancer	0.000144	0.00397	CcSEcCtD
Apixaban—Skin disorder—Methotrexate—esophageal cancer	0.000142	0.00394	CcSEcCtD
Apixaban—Hypotension—Methotrexate—esophageal cancer	0.000137	0.00379	CcSEcCtD
Apixaban—Dizziness—Capecitabine—esophageal cancer	0.00013	0.0036	CcSEcCtD
Apixaban—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000127	0.0035	CcSEcCtD
Apixaban—Rash—Capecitabine—esophageal cancer	0.000124	0.00344	CcSEcCtD
Apixaban—Dermatitis—Capecitabine—esophageal cancer	0.000124	0.00343	CcSEcCtD
Apixaban—Nausea—Capecitabine—esophageal cancer	0.000117	0.00324	CcSEcCtD
Apixaban—Hypersensitivity—Methotrexate—esophageal cancer	0.000108	0.00299	CcSEcCtD
Apixaban—Dizziness—Methotrexate—esophageal cancer	9.7e-05	0.00268	CcSEcCtD
Apixaban—Rash—Methotrexate—esophageal cancer	9.25e-05	0.00256	CcSEcCtD
Apixaban—Dermatitis—Methotrexate—esophageal cancer	9.24e-05	0.00256	CcSEcCtD
Apixaban—Nausea—Methotrexate—esophageal cancer	8.71e-05	0.00241	CcSEcCtD
Apixaban—CYP3A5—Metabolism—CYP26A1—esophageal cancer	3.42e-05	0.000197	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.41e-05	0.000196	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CA2—esophageal cancer	3.41e-05	0.000196	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYP2A6—esophageal cancer	3.4e-05	0.000196	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—NOS3—esophageal cancer	3.36e-05	0.000194	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALOX15—esophageal cancer	3.34e-05	0.000192	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.25e-05	0.000187	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ADH7—esophageal cancer	3.25e-05	0.000187	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PLCE1—esophageal cancer	3.25e-05	0.000187	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS1—esophageal cancer	3.23e-05	0.000186	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ENO1—esophageal cancer	3.23e-05	0.000186	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.22e-05	0.000186	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.21e-05	0.000185	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ADH1B—esophageal cancer	3.19e-05	0.000184	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CA2—esophageal cancer	3.18e-05	0.000183	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—TPI1—esophageal cancer	3.18e-05	0.000183	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTO1—esophageal cancer	3.18e-05	0.000183	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PSME2—esophageal cancer	3.18e-05	0.000183	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PSME1—esophageal cancer	3.18e-05	0.000183	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PLCE1—esophageal cancer	3.17e-05	0.000182	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ADH7—esophageal cancer	3.17e-05	0.000182	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.14e-05	0.000181	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.13e-05	0.00018	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.11e-05	0.000179	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PTGS2—esophageal cancer	3.07e-05	0.000177	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALDOB—esophageal cancer	3.05e-05	0.000176	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—TYMP—esophageal cancer	3.05e-05	0.000175	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	2.99e-05	0.000172	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CA1—esophageal cancer	2.97e-05	0.000171	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC10A2—esophageal cancer	2.97e-05	0.000171	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP26A1—esophageal cancer	2.96e-05	0.000171	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PLCE1—esophageal cancer	2.96e-05	0.00017	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ADH7—esophageal cancer	2.96e-05	0.00017	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GAPDH—esophageal cancer	2.94e-05	0.000169	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.93e-05	0.000168	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CRABP1—esophageal cancer	2.91e-05	0.000168	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALOX15—esophageal cancer	2.89e-05	0.000166	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ADH1B—esophageal cancer	2.85e-05	0.000164	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ADH1B—esophageal cancer	2.78e-05	0.00016	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GNG7—esophageal cancer	2.77e-05	0.000159	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTO1—esophageal cancer	2.76e-05	0.000159	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—TPI1—esophageal cancer	2.76e-05	0.000159	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYP1B1—esophageal cancer	2.74e-05	0.000158	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CA2—esophageal cancer	2.72e-05	0.000157	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—TYMP—esophageal cancer	2.72e-05	0.000157	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.72e-05	0.000156	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.7e-05	0.000155	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.7e-05	0.000155	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.66e-05	0.000153	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—TYMP—esophageal cancer	2.65e-05	0.000153	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP26A1—esophageal cancer	2.65e-05	0.000152	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALDOB—esophageal cancer	2.64e-05	0.000152	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.61e-05	0.00015	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.6e-05	0.000149	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALDH2—esophageal cancer	2.59e-05	0.000149	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.58e-05	0.000149	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYP19A1—esophageal cancer	2.58e-05	0.000149	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALOX15—esophageal cancer	2.58e-05	0.000148	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—EP300—esophageal cancer	2.56e-05	0.000147	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.55e-05	0.000147	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GAPDH—esophageal cancer	2.54e-05	0.000146	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ADH7—esophageal cancer	2.53e-05	0.000146	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PLCE1—esophageal cancer	2.53e-05	0.000146	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CRABP1—esophageal cancer	2.52e-05	0.000145	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALOX15—esophageal cancer	2.52e-05	0.000145	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.5e-05	0.000144	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—TYMP—esophageal cancer	2.48e-05	0.000143	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTT1—esophageal cancer	2.47e-05	0.000142	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTO1—esophageal cancer	2.46e-05	0.000142	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—TPI1—esophageal cancer	2.46e-05	0.000142	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP2A6—esophageal cancer	2.44e-05	0.00014	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.41e-05	0.000139	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTO1—esophageal cancer	2.4e-05	0.000138	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—TPI1—esophageal cancer	2.4e-05	0.000138	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GNG7—esophageal cancer	2.4e-05	0.000138	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALDOB—esophageal cancer	2.36e-05	0.000136	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—HMOX1—esophageal cancer	2.35e-05	0.000136	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALOX15—esophageal cancer	2.35e-05	0.000135	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ENO1—esophageal cancer	2.31e-05	0.000133	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS1—esophageal cancer	2.31e-05	0.000133	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALDOB—esophageal cancer	2.3e-05	0.000133	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.3e-05	0.000132	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CA1—esophageal cancer	2.3e-05	0.000132	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PSME2—esophageal cancer	2.28e-05	0.000131	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PSME1—esophageal cancer	2.28e-05	0.000131	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GAPDH—esophageal cancer	2.27e-05	0.000131	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ABCB1—esophageal cancer	2.26e-05	0.00013	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CRABP1—esophageal cancer	2.25e-05	0.00013	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALDH2—esophageal cancer	2.25e-05	0.000129	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTO1—esophageal cancer	2.24e-05	0.000129	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—TPI1—esophageal cancer	2.24e-05	0.000129	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ADH1B—esophageal cancer	2.22e-05	0.000128	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GAPDH—esophageal cancer	2.22e-05	0.000128	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.21e-05	0.000127	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CRABP1—esophageal cancer	2.2e-05	0.000126	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALDOB—esophageal cancer	2.15e-05	0.000124	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GNG7—esophageal cancer	2.14e-05	0.000123	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.14e-05	0.000123	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTT1—esophageal cancer	2.14e-05	0.000123	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—TYMP—esophageal cancer	2.12e-05	0.000122	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP2A6—esophageal cancer	2.11e-05	0.000122	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.1e-05	0.000121	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CA2—esophageal cancer	2.1e-05	0.000121	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GNG7—esophageal cancer	2.09e-05	0.00012	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GAPDH—esophageal cancer	2.07e-05	0.000119	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP26A1—esophageal cancer	2.06e-05	0.000119	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CRABP1—esophageal cancer	2.05e-05	0.000118	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALOX15—esophageal cancer	2.01e-05	0.000116	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALDH2—esophageal cancer	2.01e-05	0.000115	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS1—esophageal cancer	2e-05	0.000115	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ENO1—esophageal cancer	2e-05	0.000115	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PSME2—esophageal cancer	1.97e-05	0.000114	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PSME1—esophageal cancer	1.97e-05	0.000114	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP1B1—esophageal cancer	1.97e-05	0.000113	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALDH2—esophageal cancer	1.96e-05	0.000113	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.95e-05	0.000112	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ADH7—esophageal cancer	1.95e-05	0.000112	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GNG7—esophageal cancer	1.95e-05	0.000112	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—TPI1—esophageal cancer	1.92e-05	0.00011	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.92e-05	0.00011	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.91e-05	0.00011	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PIK3CA—esophageal cancer	1.89e-05	0.000109	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.89e-05	0.000109	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.88e-05	0.000108	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTT1—esophageal cancer	1.86e-05	0.000107	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP19A1—esophageal cancer	1.85e-05	0.000106	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.84e-05	0.000106	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.84e-05	0.000106	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.83e-05	0.000105	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ENO1—esophageal cancer	1.79e-05	0.000103	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.79e-05	0.000103	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.77e-05	0.000102	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PSME2—esophageal cancer	1.76e-05	0.000101	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PSME1—esophageal cancer	1.76e-05	0.000101	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.75e-05	0.000101	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS1—esophageal cancer	1.74e-05	0.0001	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ENO1—esophageal cancer	1.74e-05	0.0001	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.74e-05	0.0001	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.74e-05	0.0001	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.72e-05	9.92e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.72e-05	9.9e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PSME2—esophageal cancer	1.72e-05	9.9e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PSME1—esophageal cancer	1.72e-05	9.9e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.71e-05	9.86e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.71e-05	9.85e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.7e-05	9.8e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—HMOX1—esophageal cancer	1.69e-05	9.71e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GNG7—esophageal cancer	1.67e-05	9.6e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—TYMP—esophageal cancer	1.64e-05	9.42e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.63e-05	9.38e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ENO1—esophageal cancer	1.63e-05	9.38e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ABCB1—esophageal cancer	1.62e-05	9.32e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PSME2—esophageal cancer	1.61e-05	9.25e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PSME1—esophageal cancer	1.61e-05	9.25e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.6e-05	9.22e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.59e-05	9.16e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.56e-05	9e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.55e-05	8.93e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.54e-05	8.86e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.52e-05	8.75e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CREBBP—esophageal cancer	1.51e-05	8.69e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTT1—esophageal cancer	1.49e-05	8.56e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.48e-05	8.54e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.48e-05	8.52e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—TPI1—esophageal cancer	1.48e-05	8.52e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.47e-05	8.46e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.46e-05	8.43e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.46e-05	8.41e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.43e-05	8.25e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.43e-05	8.23e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.42e-05	8.17e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.4e-05	8.07e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.4e-05	8.07e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.39e-05	8.03e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ENO1—esophageal cancer	1.39e-05	8.02e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.39e-05	8.02e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.39e-05	7.98e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PSME2—esophageal cancer	1.37e-05	7.9e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PSME1—esophageal cancer	1.37e-05	7.9e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.37e-05	7.86e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.35e-05	7.79e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—NOS3—esophageal cancer	1.35e-05	7.78e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.3e-05	7.51e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.3e-05	7.5e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GNG7—esophageal cancer	1.29e-05	7.41e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.28e-05	7.36e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—HMOX1—esophageal cancer	1.27e-05	7.33e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.25e-05	7.21e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS2—esophageal cancer	1.24e-05	7.12e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.21e-05	6.94e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.2e-05	6.9e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.19e-05	6.85e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.18e-05	6.82e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.17e-05	6.72e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.15e-05	6.6e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.14e-05	6.57e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.13e-05	6.53e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.11e-05	6.41e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.08e-05	6.23e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.07e-05	6.19e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ENO1—esophageal cancer	1.07e-05	6.19e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.06e-05	6.1e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PSME1—esophageal cancer	1.06e-05	6.1e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PSME2—esophageal cancer	1.06e-05	6.1e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—EP300—esophageal cancer	1.03e-05	5.92e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.02e-05	5.85e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.97e-06	5.74e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ABCB1—esophageal cancer	9.75e-06	5.61e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—NOS3—esophageal cancer	9.69e-06	5.58e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.46e-06	5.45e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CREBBP—esophageal cancer	9.37e-06	5.4e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP1B1—esophageal cancer	9.14e-06	5.26e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS2—esophageal cancer	8.86e-06	5.1e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.63e-06	4.97e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP19A1—esophageal cancer	8.59e-06	4.95e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NOS3—esophageal cancer	8.39e-06	4.83e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CREBBP—esophageal cancer	8.36e-06	4.82e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CREBBP—esophageal cancer	8.16e-06	4.7e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HMOX1—esophageal cancer	7.84e-06	4.51e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS2—esophageal cancer	7.67e-06	4.42e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CREBBP—esophageal cancer	7.63e-06	4.39e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CA—esophageal cancer	7.61e-06	4.38e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCB1—esophageal cancer	7.53e-06	4.33e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NOS3—esophageal cancer	7.49e-06	4.31e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.37e-06	4.24e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—EP300—esophageal cancer	7.37e-06	4.24e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NOS3—esophageal cancer	7.31e-06	4.21e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS2—esophageal cancer	6.85e-06	3.94e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NOS3—esophageal cancer	6.83e-06	3.93e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS2—esophageal cancer	6.68e-06	3.85e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CREBBP—esophageal cancer	6.52e-06	3.75e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—EP300—esophageal cancer	6.38e-06	3.67e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS2—esophageal cancer	6.24e-06	3.6e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NOS3—esophageal cancer	5.83e-06	3.36e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—EP300—esophageal cancer	5.7e-06	3.28e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—EP300—esophageal cancer	5.56e-06	3.2e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CA—esophageal cancer	5.45e-06	3.14e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS2—esophageal cancer	5.34e-06	3.07e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—EP300—esophageal cancer	5.19e-06	2.99e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.03e-06	2.9e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CA—esophageal cancer	4.72e-06	2.72e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NOS3—esophageal cancer	4.5e-06	2.59e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—EP300—esophageal cancer	4.44e-06	2.56e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CA—esophageal cancer	4.21e-06	2.43e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.12e-06	2.37e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CA—esophageal cancer	4.11e-06	2.37e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3.84e-06	2.21e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—EP300—esophageal cancer	3.43e-06	1.97e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CA—esophageal cancer	3.28e-06	1.89e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.53e-06	1.46e-05	CbGpPWpGaD
